Community Clinical Trials

Orange, California 92868

1 studies enrolling now · 25 studies all time

What they study most

Breast Cancer, Chronic Idiopathic Constipation, Colonic Diseases, Crohn's Disease, Diabetes, Diarrhea, Diarrhea Predominant Irritable Bowel Syndrome, Gastrointestinal Disease, Gastroparesis, Hepatitis C, Chronic, Inflammatory Bowel Disease, Irritable Bowel Syndrome

Studies at this site

• A Study to Test Inavolisib Treatments in Participants With Early-Stage, PIK3CA-Mutated Breast Cancer — Recruiting now
• Addition of ISIS 14803 to Therapy With Peginterferon and Ribavirin for Chronic Hepatitis C (HCV) Patients Not Responding Adequately to the Two Drugs — Completed
• A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis — Completed
• Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease — Completed
• Long-Term Safety Of PF-00547659 In Ulcerative Colitis — Completed
• A Study To Monitor Long-Term Treatment With PF-00547659 — Completed
• Diarrhea Predominant Irritable Bowel Syndrome in Females — Completed
• A Study of Crofelemer to Treat Diarrhea Irritable Bowel Syndrome — Completed
• New Tablet Formulation and Dosing Regimen of Balsalazide Disodium in Mildly to Moderately Active Ulcerative Colitis — Completed
• Long-Term Safety and Tolerability of Mesalamine Pellets in Participants With Ulcerative Colitis in Remission — Completed
• Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study — Completed
• The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C) — Completed
• The Plecanatide Chronic Idiopathic Constipation (CIC) Study — Completed
• A Clinical Trial of Natalizumab in Individuals With Moderately to Severely Active Crohn's Disease — Completed
• Safety and Efficacy of Two Different Doses of Asacol in the Treatment of Moderately Active Ulcerative Colitis — Completed
• A Phase 3 Study of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise — Completed
• Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) — Completed
• LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) — Completed
• Asimadoline for the Treatment of Subjects With Irritable Bowel Syndrome — Completed
• CP-461 for the Treatment of Crohn's Disease — Completed
• A Study of 3 Doses of Dextofisopam in Females With Irritable Bowel Syndrome — Completed
• Study of LX1031 in Subjects With Non-Constipating Irritable Bowel Syndrome — Completed
• Study of STA-5326 Mesylate in Patients With Moderate to Severe Crohn's Disease — Completed
• Safety and Efficacy of OP2000 (Deligoparin) in the Treatment of Active Ulcerative Colitis — Completed
• Safety and Effectiveness of an Investigational Agent (GM-611) in Patients With Diabetic Gastroparesis — Completed